Jan 03, 2025
Category
Equity
AUM (Cr.)
0.00
Exit Load (%)
1.00
Min Inv Lumpsum
500
Expense Ratio
0.00
Sharpe Ratio
0.00
Beta Ratio
0.00
Fund Manager
Nimesh Chandan
Inception Date
Risk Level
Very High
Investment Objective
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.